2-(trifluoromethyl)-6,7,8,9-tetrahydro-4H-pyrimido[1,2-a]pyrimidin-4-one, 95.0%, 500mg

N,N,N-Trimethyloctan-1-aminium bromide, 95.0%, 5g

l-Valine methyl ester hydrochloride, 99.0%, 25g

2-ACETYL-4-METHYLPHENYL BENZOATE, 95.0%, 1g

tert-butyl rac-[(1R,3R)-3-aminocyclohexyl]carbamate, 95.0%, 500mg

4-Fluoro-1-naphthalenemethanamine, 98.0%, 100mg

Tert-butyl 4-(4-(4-(ethoxycarbonyl)-1H-pyrazol-1-yl)pyridin-2-yl)piperazine-1-carboxylate, 98%, 1g

GC capillary column ROTI®Cap-1701 MS, 30 m, 0.25 mm, 0.25 µm, 1 Piece(s)

(4-Chloro-pyrimidin-2-yl)-ethyl-amine, 95.0%, 1g

Methyl 4-chloro-6-methylnicotinate, 95.0%, 5g

5,6,7,8-Tetrahydroquinolin-3-ol, 95.0%, 1g

2,3-Bis((R)-tert-butyl(methyl)phosphino)quinoxaline, 95.0%, 250mg

N-(4-bromophenyl)guanidine, 95.0%, 1g